We have described somehow similar effects in a thyroid carcinoma cell line, where inhibition of MEK/ERK1/2 signalling inhibits proliferation, but promotes migration, an effect that can be prevented by a parallel inhibition of the PI3/Akt pathway [26]. Here, MAP2K7 is linked to thyroid gland carcinoma.